Applying Neuromodulation to Accelerate Training Effects

Cognition Clinical Trial

— ANeMATE  

Official title:

Applying Neuromodulation to Accelerate Training Effects

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03224559
• Other study ID #: STUDY00001248
• Status: Withdrawn
• Start date: September 1, 2019
• Est. completion date: May 30, 2021

Study information

• Verified date: November 2019
• Source: University of Minnesota
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study seeks to understand at how noninvasive electrical brain stimulation might change how people perform on on tasks requiring concentration and thinking skills.

Description:

This study uses noninvasive electrical stimulation delivered through seeks to understand at how noninvasive electrical brain stimulation might change how people perform on on tasks requiring concentration and thinking skills.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: May 30, 2021
• Est. primary completion date: May 30, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

People may participate in the experiment if they have normal or corrected vision, are in good health, and are at least 18 years old.

Exclusion Criteria:

People will be screened and excluded from participation if they are currently ill or if they report any history of seizures, if they lack the capacity to consent or appear to lack capacity to consent, if they have participated in previous thinking skills training or brain stimulation, or if they are currently taking certain substances/medications that might change thinking skills.

Related Conditions & MeSH terms

• Cognition

Intervention

Device:
• Transcranial Electrical Stimulation
Transcranial Electrical Stimulation

Locations

Country	Name	City	State
United States	University of Minnesota	Minneapolis	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Working memory	Working Memory	Baseline through 2 months